JPRN-UMIN000022661已完成未知
The influence of sulfonylurea or dipeptidyl-peptidase-4 inhibitor on glucose control and the secretion of glucagon and insulin induced by sodium glucose transporter-2 inhibitor in type2 diabetic patients - The influence of sulfonylurea or dipeptidyl-peptidase-4 inhibitor on the secretion of glucagon and insulin induced by sodium glucose transporter-2 inhibitor
Chiba Central Medical Center, Diabetes Center0 个研究点目标入组 20 人开始时间: 2016年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Malignancy 2. Renal dysfunction(eGFR<60ml/min) 3. Liver dysfunction(AST>100U/l and/or ALT100>100U/l), except of fatty liver or non-alcoholic steatohepatitis 4. Pregnancy 5. Lactation 6. History of treatment for ischemic heart disease or other severe cardiovascular disease 7. Administration of any drugs affecting plasma glucose concentration
研究者
相似试验
已完成
4 期
Efficacy of Sitagliptin added to sulfonylurea in subjects with poorly controlled type 2 diabetes (STRICT-1)Type 2 Diabetes MellitusJPRN-UMIN000005178STRICT study Group200
已完成
不适用
Treatment of Diabetic Foot with Glutamine DipeptideType two diabetes and diabetic foot complicationNutritional, Metabolic, EndocrineISRCTN10878185State University of Maringá50
已完成
不适用
Sitagliptin Add-on to Sulfonylurea Studytype 2 diabetesJPRN-UMIN000005498Kyoto University80
已完成
不适用
The effect of leucine and nandrolone decanoate supplementation on muscle loss during immobilisatioDisuse atrophymuscle loss10028302NL-OMON41995niversiteit Maastricht30
招募中
Unknown
Role of glibenclamide in head injuryCTRI/2023/12/060716ICMR